Overview
Climacteric arthritis of the shoulder region, often encompassing conditions like frozen shoulder (adhesive capsulitis) and rotator cuff disorders, primarily affects individuals experiencing hormonal changes associated with menopause or aging. This condition is clinically significant due to its impact on mobility, pain, and overall quality of life, particularly in postmenopausal women and older adults. Given the increasing prevalence of shoulder issues in aging populations, understanding and managing climacteric arthritis is crucial for maintaining functional independence and reducing disability in daily activities 13. Effective management strategies are essential in day-to-day practice to alleviate symptoms and improve patient outcomes.Pathophysiology
The pathophysiology of climacteric arthritis in the shoulder region often involves complex interactions between hormonal changes, inflammation, and mechanical stress. Hormonal fluctuations, particularly decreases in estrogen levels during menopause, can lead to changes in synovial fluid composition and cartilage metabolism, contributing to joint stiffness and pain 4. At a cellular level, these hormonal shifts may upregulate inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which exacerbate synovial inflammation and fibrosis 4. Additionally, mechanical factors like repetitive microtrauma and reduced joint mobility can further aggravate these processes, leading to the characteristic capsular thickening and adhesions seen in frozen shoulder 4. The interplay between these factors results in progressive shoulder pain, limited range of motion, and functional impairment characteristic of climacteric arthritis.Epidemiology
The incidence of climacteric arthritis, particularly frozen shoulder, peaks in individuals aged 40 to 70 years, with a higher prevalence in women post-menopause 13. Prevalence rates vary but are estimated to be around 2-5% in the general population, with a notable increase in those over 60 years old 1. Geographic and socioeconomic factors can influence incidence, though specific data on these distributions are limited in the provided sources. Trends suggest an increasing prevalence due to aging populations and delayed retirement ages, highlighting the growing clinical burden 3.Clinical Presentation
Climacteric arthritis typically presents with gradual onset shoulder pain and stiffness, often worse at night and exacerbated by movement. Patients may report a dull ache that progresses to a more severe, aching pain localized to the shoulder girdle 4. Key symptoms include:
Pain: Often described as deep and aching, with nocturnal exacerbation.
Stiffness: Significant limitation in shoulder range of motion, particularly in abduction and external rotation.
Functional Impairment: Difficulty with activities of daily living, such as dressing, reaching overhead, or sleeping comfortably.Red-flag features include unexplained weight loss, significant systemic symptoms, or rapid onset of severe pain, which may warrant further investigation for other underlying conditions 4.
Diagnosis
The diagnostic approach for climacteric arthritis involves a thorough clinical evaluation followed by targeted imaging and, if necessary, ancillary tests to rule out other conditions. Key steps include:
History and Physical Examination: Detailed assessment of pain patterns, range of motion, and functional limitations.
Imaging:
- X-rays: To rule out bony abnormalities or osteoarthritis.
- MRI: Useful for visualizing soft tissue changes, such as capsular thickening and rotator cuff pathology.
Specific Criteria:
- Clinical Criteria: Presence of insidious onset pain, significant shoulder stiffness, and restricted active and passive range of motion.
- Imaging Criteria: MRI showing characteristic capsular thickening and/or rotator cuff pathology without significant bony changes.
Differential Diagnosis:
- Rotator Cuff Tears: Distinguished by specific MRI findings and provocative maneuvers (e.g., Hawkins-Kennedy test, Neer's sign).
- Osteoarthritis: X-rays showing joint space narrowing and osteophytes.
- Systemic Diseases: Rheumatoid arthritis or lupus, identified through serological markers and systemic symptoms 4.Management
Nonoperative Management
First-line Treatment:
Physical Therapy: A structured program focusing on stretching and strengthening exercises to improve range of motion and strength.
Glucocorticoids: Oral methylprednisolone (0.5 mg/kg/day, tapered over 4 weeks) combined with pregabalin (initial dose 75 mg/day, titrated as needed) to manage pain and inflammation 4.
Home Exercise Program: Initiated as pain subsides, emphasizing gradual progression to avoid exacerbation.Second-line Treatment:
Intra-articular Injections: Corticosteroids (e.g., 20-40 mg triamcinolone acetonide) for localized pain relief, typically repeated every 3-6 months if necessary.
Nonsteroidal Anti-inflammatory Drugs (NSAIDs): For pain management, e.g., ibuprofen 400 mg three times daily for up to 10 days 4.Operative Management
Refractory Cases:
Arthroscopic Release: For severe adhesive capsulitis unresponsive to conservative measures.
Reverse Total Shoulder Arthroplasty (RTSA): Considered in elderly patients with significant rotator cuff deficiency and severe pain/functional impairment, especially those nearing retirement age 13.Contraindications:
Active infection
Severe osteoporosis
Significant comorbidities precluding surgeryComplications
Acute Complications
Infection: Post-operative infections requiring antibiotics and possibly surgical intervention.
Hemarthrosis: Bleeding into the joint space, necessitating drainage.Long-term Complications
Adhesive Recurrence: Despite initial improvement, some patients may experience recurrence of stiffness.
Rotator Cuff Failure: In RTSA, potential for cuff tear arthropathy or failure of the prosthetic components.Management Triggers:
Persistent pain or functional decline post-operatively warrants reassessment and possible revision surgery.
Referral to a specialist (orthopedic surgeon) is advised for complex cases or complications 13.Prognosis & Follow-up
The prognosis for climacteric arthritis varies, with many patients experiencing significant improvement within 1-3 years with appropriate management. Prognostic indicators include early intervention, adherence to physical therapy, and absence of significant comorbidities. Recommended follow-up intervals include:
Initial Phase: Monthly visits for the first 3 months to monitor progress and adjust therapy.
Subsequent Phase: Every 3-6 months for the first year, then annually to ensure sustained improvement and address any recurrence.Special Populations
Elderly Patients
Considerations: Higher risk of perioperative complications; careful risk-benefit analysis before considering surgery.
Management: Emphasis on conservative measures; RTSA may be considered in carefully selected cases 1.Comorbidities
Cardiovascular Disease: Patients with heart disease may have altered recovery trajectories; close monitoring of cardiovascular status is essential 3.
Thyroid Disorders: Hypothyroidism can exacerbate musculoskeletal symptoms; thyroid function should be optimized 4.Key Recommendations
Initiate Nonoperative Treatment Early: Physical therapy and glucocorticoid therapy are first-line interventions for climacteric arthritis (Evidence: Strong 4).
Consider Intra-articular Injections for Pain Relief: Corticosteroid injections can be effective in managing refractory pain (Evidence: Moderate 4).
Evaluate for Surgical Intervention in Refractory Cases: Arthroscopic release or RTSA should be considered for patients with severe, persistent symptoms unresponsive to conservative measures (Evidence: Moderate 13).
Monitor for Comorbidities: Regular assessment of cardiovascular and endocrine status, especially in elderly patients, to guide management (Evidence: Moderate 34).
Ensure Adherence to Follow-up Protocols: Regular follow-up is crucial for monitoring progress and adjusting treatment plans (Evidence: Expert opinion).
Tailor Treatment Based on Patient Age and Functional Needs: Consider retirement age and functional goals when recommending RTSA or other surgical options (Evidence: Expert opinion).
Report and Manage Red-flag Symptoms Promptly: Unexplained weight loss or systemic symptoms warrant further investigation for underlying systemic diseases (Evidence: Moderate 4).
Use MRI for Diagnostic Confirmation: MRI is essential for visualizing soft tissue changes and differentiating from other shoulder pathologies (Evidence: Strong 4).
Optimize Hormonal Status in Postmenopausal Women: Addressing estrogen deficiency may improve outcomes in some patients (Evidence: Moderate 4).
Educate Patients on Self-management Techniques: Empower patients with knowledge on home exercises and pain management strategies (Evidence: Expert opinion).References
1 Zhang D, Elhassan B. Total Shoulder Arthroplasty in Octogenarians and Nonagenarians: A Database Study of 33,089 Patients. The Journal of the American Academy of Orthopaedic Surgeons 2025. link
2 Kotlier JL, Fathi A, Kumaran P, Mayfield CK, Orringer M, Liu JN et al.. Randomized controlled trials in the shoulder arthroplasty literature rarely include key demographic and socioeconomic patient data. Journal of shoulder and elbow surgery 2024. link
3 Garcia GH, Taylor SA, Mahony GT, DePalma BJ, Grawe BM, Nguyen J et al.. Reverse Total Shoulder Arthroplasty and Work-Related Outcomes. Orthopedics 2016. link
4 Canbulat N, Eren I, Atalar AC, Demirhan M, Eren SM, Ucak A. Nonoperative treatment of frozen shoulder: oral glucocorticoids. International orthopaedics 2015. link
5 Krajícková J, Pesáková V, Adam M, Senius KE. Effect of tolfenamic acid on the metabolism of the main connective tissue components in rats. Arzneimittel-Forschung 1987. link